Hinge Health, Inc. (NYSE: HNGE) Stock Competitors & Peer Comparison

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while GEHCV trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas GEHCV's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, HNGE is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check GEHCV's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, BTSG has a market cap of 12B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while BTSG trades at $60.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas BTSG's P/E ratio is 41.41. In terms of profitability, HNGE's ROE is +0.30%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, HNGE is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check BTSG's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, BTSGU has a market cap of 11.8B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while BTSGU trades at $197.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas BTSGU's P/E ratio is 136.08. In terms of profitability, HNGE's ROE is +0.30%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, HNGE is less volatile compared to BTSGU. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check BTSGU's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, TEM has a market cap of 11.4B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while TEM trades at $64.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas TEM's P/E ratio is -129.44. In terms of profitability, HNGE's ROE is +0.30%, compared to TEM's ROE of -0.55%. Regarding short-term risk, HNGE is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check TEM's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while SGFY trades at $30.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas SGFY's P/E ratio is 70.91. In terms of profitability, HNGE's ROE is +0.30%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, HNGE is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check SGFY's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, HQY has a market cap of 7.6B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while HQY trades at $92.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas HQY's P/E ratio is 21.50. In terms of profitability, HNGE's ROE is +0.30%, compared to HQY's ROE of +0.11%. Regarding short-term risk, HNGE is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check HQY's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while RCM trades at $14.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas RCM's P/E ratio is -102.21. In terms of profitability, HNGE's ROE is +0.30%, compared to RCM's ROE of +0.00%. Regarding short-term risk, HNGE is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check RCM's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, DOCS has a market cap of 5.5B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while DOCS trades at $30.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas DOCS's P/E ratio is 20.25. In terms of profitability, HNGE's ROE is +0.30%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, HNGE is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check DOCS's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, WAY has a market cap of 5.2B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while WAY trades at $27.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas WAY's P/E ratio is 18.12. In terms of profitability, HNGE's ROE is +0.30%, compared to WAY's ROE of +0.04%. Regarding short-term risk, HNGE is less volatile compared to WAY. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check WAY's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, HTFL has a market cap of 4.2B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while HTFL trades at $50.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas HTFL's P/E ratio is -24.02. In terms of profitability, HNGE's ROE is +0.30%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, HNGE is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check HTFL's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while ONEM trades at $16.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas ONEM's P/E ratio is -7.77. In terms of profitability, HNGE's ROE is +0.30%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, HNGE is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check ONEM's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, PRVA has a market cap of 2.9B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while PRVA trades at $22.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas PRVA's P/E ratio is 107.24. In terms of profitability, HNGE's ROE is +0.30%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, HNGE is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check PRVA's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, OMCL has a market cap of 1.6B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while OMCL trades at $35.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas OMCL's P/E ratio is 18.53. In terms of profitability, HNGE's ROE is +0.30%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, HNGE is less volatile compared to OMCL. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check OMCL's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while NXGN trades at $23.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas NXGN's P/E ratio is -266.00. In terms of profitability, HNGE's ROE is +0.30%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, HNGE is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check NXGN's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, CERT has a market cap of 1.4B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while CERT trades at $9.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas CERT's P/E ratio is 23.42. In terms of profitability, HNGE's ROE is +0.30%, compared to CERT's ROE of -0.07%. Regarding short-term risk, HNGE is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check CERT's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while AGTI trades at $10.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas AGTI's P/E ratio is -71.79. In terms of profitability, HNGE's ROE is +0.30%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, HNGE is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check AGTI's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, GDRX has a market cap of 1.1B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while GDRX trades at $3.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas GDRX's P/E ratio is 10.50. In terms of profitability, HNGE's ROE is +0.30%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, HNGE is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check GDRX's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, OMDA has a market cap of 1.1B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while OMDA trades at $17.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas OMDA's P/E ratio is 76.65. In terms of profitability, HNGE's ROE is +0.30%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, HNGE is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check OMDA's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, TDOC has a market cap of 1B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while TDOC trades at $5.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas TDOC's P/E ratio is -5.73. In terms of profitability, HNGE's ROE is +0.30%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, HNGE is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check TDOC's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, HSTM has a market cap of 1B. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while HSTM trades at $33.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas HSTM's P/E ratio is 46.01. In terms of profitability, HNGE's ROE is +0.30%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, HNGE is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check HSTM's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while CCLDO trades at $27.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas CCLDO's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, HNGE is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check CCLDO's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, PHR has a market cap of 678.7M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while PHR trades at $10.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas PHR's P/E ratio is 39.05. In terms of profitability, HNGE's ROE is +0.30%, compared to PHR's ROE of +0.03%. Regarding short-term risk, HNGE is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check PHR's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while MPLN-WT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, HNGE is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check MPLN-WT's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while ACCD trades at $7.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas ACCD's P/E ratio is -3.08. In terms of profitability, HNGE's ROE is +0.30%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, HNGE is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check ACCD's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, SOPH has a market cap of 572.9M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while SOPH trades at $6.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas SOPH's P/E ratio is -6.06. In terms of profitability, HNGE's ROE is +0.30%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, HNGE is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check SOPH's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while SHCR trades at $1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas SHCR's P/E ratio is -3.76. In terms of profitability, HNGE's ROE is +0.30%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, HNGE is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check SHCR's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, EVH has a market cap of 514.6M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while EVH trades at $4.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas EVH's P/E ratio is 35.19. In terms of profitability, HNGE's ROE is +0.30%, compared to EVH's ROE of -0.99%. Regarding short-term risk, HNGE is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check EVH's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, NRC has a market cap of 445.7M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while NRC trades at $20.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas NRC's P/E ratio is 24.57. In terms of profitability, HNGE's ROE is +0.30%, compared to NRC's ROE of +0.48%. Regarding short-term risk, HNGE is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check NRC's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while SLGCW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, HNGE's ROE is +0.30%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, HNGE is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check SLGCW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while SLGC trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas SLGC's P/E ratio is -3.04. In terms of profitability, HNGE's ROE is +0.30%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, HNGE is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check SLGC's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while TBRG trades at $26.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas TBRG's P/E ratio is 9.37. In terms of profitability, HNGE's ROE is +0.30%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, HNGE is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check TBRG's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while MPLN trades at $23.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas MPLN's P/E ratio is -0.23. In terms of profitability, HNGE's ROE is +0.30%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, HNGE is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check MPLN's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, CTEV has a market cap of 374.2M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while CTEV trades at $22.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas CTEV's P/E ratio is -1.30. In terms of profitability, HNGE's ROE is +0.30%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, HNGE is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check CTEV's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, CARL has a market cap of 367.2M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while CARL trades at $13.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas CARL's P/E ratio is -9.41. In terms of profitability, HNGE's ROE is +0.30%, compared to CARL's ROE of -0.38%. Regarding short-term risk, HNGE is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check CARL's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, SY has a market cap of 296.9M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while SY trades at $2.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas SY's P/E ratio is -6.88. In terms of profitability, HNGE's ROE is +0.30%, compared to SY's ROE of -0.16%. Regarding short-term risk, HNGE is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check SY's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while TRHC trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas TRHC's P/E ratio is -4.27. In terms of profitability, HNGE's ROE is +0.30%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, HNGE is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check TRHC's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while SMFR trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas SMFR's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, HNGE is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check SMFR's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, SPOK has a market cap of 221.6M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while SPOK trades at $10.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas SPOK's P/E ratio is 17.68. In terms of profitability, HNGE's ROE is +0.30%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, HNGE is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check SPOK's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, AMWL has a market cap of 197.5M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while AMWL trades at $11.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas AMWL's P/E ratio is -2.63. In terms of profitability, HNGE's ROE is +0.30%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, HNGE is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check AMWL's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, OPRX has a market cap of 160.1M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while OPRX trades at $8.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas OPRX's P/E ratio is 7.80. In terms of profitability, HNGE's ROE is +0.30%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, HNGE is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check OPRX's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, LFMDP has a market cap of 151.6M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while LFMDP trades at $21.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas LFMDP's P/E ratio is -685.21. In terms of profitability, HNGE's ROE is +0.30%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, HNGE is less volatile compared to LFMDP. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check LFMDP's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while CPSI trades at $9.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas CPSI's P/E ratio is -183.80. In terms of profitability, HNGE's ROE is +0.30%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, HNGE is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check CPSI's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, HCAT has a market cap of 129.8M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while HCAT trades at $1.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas HCAT's P/E ratio is 8.63. In terms of profitability, HNGE's ROE is +0.30%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, HNGE is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check HCAT's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while AUGX trades at $2.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas AUGX's P/E ratio is -4.99. In terms of profitability, HNGE's ROE is +0.30%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, HNGE is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check AUGX's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, LFMD has a market cap of 112.9M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while LFMD trades at $2.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas LFMD's P/E ratio is -4.68. In terms of profitability, HNGE's ROE is +0.30%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, HNGE is less volatile compared to LFMD. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check LFMD's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, DH has a market cap of 108.9M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while DH trades at $1.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas DH's P/E ratio is 3.92. In terms of profitability, HNGE's ROE is +0.30%, compared to DH's ROE of -0.79%. Regarding short-term risk, HNGE is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check DH's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, CCLD has a market cap of 78.6M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while CCLD trades at $1.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas CCLD's P/E ratio is 7.12. In terms of profitability, HNGE's ROE is +0.30%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, HNGE is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check CCLD's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while FORA trades at $2.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas FORA's P/E ratio is -24.11. In terms of profitability, HNGE's ROE is +0.30%, compared to FORA's ROE of -0.17%. Regarding short-term risk, HNGE is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check FORA's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while CCLDP trades at $19.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas CCLDP's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, HNGE is less volatile compared to CCLDP. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check CCLDP's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while SNCE trades at $5.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas SNCE's P/E ratio is -0.27. In terms of profitability, HNGE's ROE is +0.30%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, HNGE is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check SNCE's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while AKLI trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas AKLI's P/E ratio is -0.71. In terms of profitability, HNGE's ROE is +0.30%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, HNGE is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check AKLI's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while SHLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas SHLT's P/E ratio is -3.87. In terms of profitability, HNGE's ROE is +0.30%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, HNGE is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check SHLT's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while SHCRW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, HNGE's ROE is +0.30%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, HNGE is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check SHCRW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, ONMDW has a market cap of 29.2M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while ONMDW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas ONMDW's P/E ratio is -0.21. In terms of profitability, HNGE's ROE is +0.30%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, HNGE is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check ONMDW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, ONMD has a market cap of 26.3M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while ONMD trades at $4.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas ONMD's P/E ratio is -28.19. In terms of profitability, HNGE's ROE is +0.30%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, HNGE is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check ONMD's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while STRM trades at $5.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas STRM's P/E ratio is -2.40. In terms of profitability, HNGE's ROE is +0.30%, compared to STRM's ROE of -0.65%. Regarding short-term risk, HNGE is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check STRM's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while RNLX trades at $0.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas RNLX's P/E ratio is -0.33. In terms of profitability, HNGE's ROE is +0.30%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, HNGE is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check RNLX's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while LIFW trades at $3.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas LIFW's P/E ratio is -0.02. In terms of profitability, HNGE's ROE is +0.30%, compared to LIFW's ROE of +0.81%. Regarding short-term risk, HNGE is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check LIFW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, WORX has a market cap of 21.6M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while WORX trades at $2.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas WORX's P/E ratio is -1.57. In terms of profitability, HNGE's ROE is +0.30%, compared to WORX's ROE of -0.35%. Regarding short-term risk, HNGE is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check WORX's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while BBLN trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas BBLN's P/E ratio is -0.04. In terms of profitability, HNGE's ROE is +0.30%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, HNGE is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check BBLN's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while ETAO trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas ETAO's P/E ratio is -0.01. In terms of profitability, HNGE's ROE is +0.30%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, HNGE is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check ETAO's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, BFRG has a market cap of 9.7M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while BFRG trades at $0.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas BFRG's P/E ratio is -1.13. In terms of profitability, HNGE's ROE is +0.30%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, HNGE is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check BFRG's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, MGRX has a market cap of 6.4M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while MGRX trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas MGRX's P/E ratio is -0.21. In terms of profitability, HNGE's ROE is +0.30%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, HNGE is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check MGRX's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, HCTI has a market cap of 6M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while HCTI trades at $0.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas HCTI's P/E ratio is -0.05. In terms of profitability, HNGE's ROE is +0.30%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, HNGE is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check HCTI's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while UPH trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas UPH's P/E ratio is -0.07. In terms of profitability, HNGE's ROE is +0.30%, compared to UPH's ROE of -1.05%. Regarding short-term risk, HNGE is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check UPH's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while UPH-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to UPH-WT's ROE of -0.72%. Regarding short-term risk, HNGE is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check UPH-WT's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, ACON has a market cap of 5.3M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while ACON trades at $1.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas ACON's P/E ratio is -0.21. In terms of profitability, HNGE's ROE is +0.30%, compared to ACON's ROE of -0.59%. Regarding short-term risk, HNGE is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check ACON's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while PEAR trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas PEAR's P/E ratio is -0.08. In terms of profitability, HNGE's ROE is +0.30%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, HNGE is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check PEAR's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while PEARW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas PEARW's P/E ratio is -0.00. In terms of profitability, HNGE's ROE is +0.30%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, HNGE is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check PEARW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while OTRK trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas OTRK's P/E ratio is -0.02. In terms of profitability, HNGE's ROE is +0.30%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, HNGE is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check OTRK's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while CMAX trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas CMAX's P/E ratio is -0.00. In terms of profitability, HNGE's ROE is +0.30%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, HNGE is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check CMAX's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, BFRGW has a market cap of 1.5M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while BFRGW trades at $0.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas BFRGW's P/E ratio is -0.25. In terms of profitability, HNGE's ROE is +0.30%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, HNGE is less volatile compared to BFRGW. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check BFRGW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, VSEE has a market cap of 1.5M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while VSEE trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas VSEE's P/E ratio is -4.70. In terms of profitability, HNGE's ROE is +0.30%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, HNGE is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check VSEE's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while LIFWZ trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to LIFWZ's ROE of +0.81%. Regarding short-term risk, HNGE is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check LIFWZ's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while VSEEW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, HNGE's ROE is +0.30%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, HNGE is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check VSEEW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while MSPRZ trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to MSPRZ's ROE of +0.81%. Regarding short-term risk, HNGE is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check MSPRZ's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while KERN trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas KERN's P/E ratio is -0.01. In terms of profitability, HNGE's ROE is +0.30%, compared to KERN's ROE of -0.20%. Regarding short-term risk, HNGE is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check KERN's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while KERNW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas KERNW's P/E ratio is -0.00. In terms of profitability, HNGE's ROE is +0.30%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, HNGE is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check KERNW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while LIFWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas LIFWW's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to LIFWW's ROE of +0.81%. Regarding short-term risk, HNGE is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check LIFWW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while CMAXW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas CMAXW's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, HNGE is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check CMAXW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, ZCMD has a market cap of 22.7K. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while ZCMD trades at $1.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas ZCMD's P/E ratio is -0.04. In terms of profitability, HNGE's ROE is +0.30%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, HNGE is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check ZCMD's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, ACONW has a market cap of 14.7K. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while ACONW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas ACONW's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, HNGE is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check ACONW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, AFFX has a market cap of 0. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while AFFX trades at $14.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas AFFX's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, HNGE is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check AFFX's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while CHNGU trades at $73.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas CHNGU's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, HNGE is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check CHNGU's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, NH has a market cap of 0. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while NH trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas NH's P/E ratio is -0.12. In terms of profitability, HNGE's ROE is +0.30%, compared to NH's ROE of +0.35%. Regarding short-term risk, HNGE is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check NH's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, MTBC has a market cap of 0. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while MTBC trades at $3.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas MTBC's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, HNGE is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check MTBC's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, NAVA has a market cap of 0. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while NAVA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas NAVA's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, HNGE is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for HNGE.Check NAVA's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, CNVY has a market cap of 0. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while CNVY trades at $10.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas CNVY's P/E ratio is -71.50. In terms of profitability, HNGE's ROE is +0.30%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, HNGE is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check CNVY's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, CHNG has a market cap of 0. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while CHNG trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas CHNG's P/E ratio is -152.72. In terms of profitability, HNGE's ROE is +0.30%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, HNGE is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check CHNG's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while SMFRW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas SMFRW's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, HNGE is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check SMFRW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, IMS has a market cap of 0. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while IMS trades at $31.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas IMS's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to IMS's ROE of +0.27%. Regarding short-term risk, HNGE is less volatile compared to IMS. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check IMS's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, KURIU has a market cap of 0. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while KURIU trades at $9.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas KURIU's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, HNGE is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check KURIU's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while MSPRV trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas MSPRV's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to MSPRV's ROE of N/A. Regarding short-term risk, HNGE is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check MSPRV's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while MTBCO trades at $25.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas MTBCO's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, HNGE is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check MTBCO's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, CERN has a market cap of 0. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while CERN trades at $94.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas CERN's P/E ratio is 55.84. In terms of profitability, HNGE's ROE is +0.30%, compared to CERN's ROE of +0.14%. Regarding short-term risk, HNGE is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check CERN's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, CSLT has a market cap of 0. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while CSLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas CSLT's P/E ratio is -37.27. In terms of profitability, HNGE's ROE is +0.30%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, HNGE is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check CSLT's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 8B. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, HNGE is priced at $101.08 on the NYSE, while MTBCP trades at $26.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 53.01, whereas MTBCP's P/E ratio is N/A. In terms of profitability, HNGE's ROE is +0.30%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, HNGE is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check MTBCP's competition here